These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12918684)

  • 1. Pathogenesis of Adamantiades-Behçet's disease.
    Zouboulis CC; May T
    Adv Exp Med Biol; 2003; 528():161-71. PubMed ID: 12918684
    [No Abstract]   [Full Text] [Related]  

  • 2. Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet's disease.
    Zouboulis CC; Turnbull JR; Martus P
    Adv Exp Med Biol; 2003; 528():123-6. PubMed ID: 12918675
    [No Abstract]   [Full Text] [Related]  

  • 3. Behçet's disease in patients of German and Turkish origin--a comparative study.
    Kötter I; Vonthein R; Günaydin I; Müller C; Kanz L; Zierhut M; Stübiger N
    Adv Exp Med Biol; 2003; 528():53-8. PubMed ID: 12918660
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA antigen, severity and acetylator phenotype in Behçet's disease patients with non-relative parents.
    Sharquie KE; Najim RA; Al-Janabi MH
    Adv Exp Med Biol; 2003; 528():139-42. PubMed ID: 12918678
    [No Abstract]   [Full Text] [Related]  

  • 5. Behçet's disease: a disease in search of its etiology.
    Roux H; Fresko I
    Rev Rhum Engl Ed; 1995 May; 62(5):339-42. PubMed ID: 7655865
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA-B51 frequency in Iranian patients with Behçet's disease.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Chams C
    Adv Exp Med Biol; 2003; 528():229-30. PubMed ID: 12918696
    [No Abstract]   [Full Text] [Related]  

  • 7. Behçet's disease: an update on the pathogenesis.
    Gül A
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S6-12. PubMed ID: 11760403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oral aphthae in Behçet's disease and idiopathic recurrent aphthous stomatitis.
    Chams-Davatchi C; Shizarpour M; Davatchi F; Shahram F; Chams H; Nadji A; Jamshidi AR
    Adv Exp Med Biol; 2003; 528():317-20. PubMed ID: 12918713
    [No Abstract]   [Full Text] [Related]  

  • 9. MICA transmembrane region polymorphism and HLA B51 in Tunisian Behçet's disease patients.
    Ben Ahmed M; Houman H; Abdelhak S; Ben Ghorbel I; Miled M; Dellagi K; Louzir H
    Adv Exp Med Biol; 2003; 528():225-8. PubMed ID: 12918695
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen.
    Yanagihori H; Oyama N; Nakamura K; Mizuki N; Oguma K; Kaneko F
    J Invest Dermatol; 2006 Jul; 126(7):1534-40. PubMed ID: 16514412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease.
    Krause L; Köhler AK; Altenburg A; Papoutsis N; Zouboulis CC; Pleyer U; Stroux A; Foerster MH
    Eye (Lond); 2009 May; 23(5):1182-6. PubMed ID: 18551141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behçet's disease (Adamantiades-Behçet's disease).
    Kaneko F; Togashi A; Saito S; Sakuma H; Oyama N; Nakamura K; Yokota K; Oguma K
    Clin Dev Immunol; 2011; 2011():681956. PubMed ID: 21052488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and molecular HLA typing in Italian Behçet's patients: significant association to B51-DR5-DQw3 haplotype.
    Balboni A; Pivetti-Pezzi P; Orlando P; Rubini M; Selvatici R; Accorinti M; Baricordi OR; Gandini E
    Tissue Antigens; 1992 Mar; 39(3):141-3. PubMed ID: 1598687
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylator phenotype in Behçet's disease.
    Najim RA; Sharquie KE; Al-Janabi MH
    Adv Exp Med Biol; 2003; 528():131-8. PubMed ID: 12918677
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of HLA-B51 with clinical expression of Behçet's disease. Analysis of 201 Iranian patients.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():147-8. PubMed ID: 12918680
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA typing for class I and class H antigens in Iraqi patients with Behçet's disease (sporadic and familial cases).
    Al-Joofy IKh; Muslih RK; Mousawy KM; Al-Waiz MM
    Adv Exp Med Biol; 2003; 528():217-20. PubMed ID: 12918693
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of familial occurrence of Behçet's disease with and without ocular lesions.
    Nishiyama M; Nakae K; Umehara T
    Jpn J Ophthalmol; 2001; 45(3):313-6. PubMed ID: 11369384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary association of HLA-B51 with Behçet's disease in Ireland.
    Benezra D
    Br J Ophthalmol; 1998 Jun; 82(6):715. PubMed ID: 9797683
    [No Abstract]   [Full Text] [Related]  

  • 19. Behçet's disease: the first Mongolian case in literature showing HLA B51, MICA gene type *5/*6.
    Chung YL; Bang DS; Lee ES; Lee SN; Mok JW; Park KS
    Yonsei Med J; 2003 Oct; 44(5):935-8. PubMed ID: 14584116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B51 negative monozygotic twins discordant for Behçet's disease.
    Gül A; Inanç M; Ocal L; Aral O; Carin M; Koniçe M
    Br J Rheumatol; 1997 Aug; 36(8):922-3. PubMed ID: 9291866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.